You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hedgehog inhibitor

Showing 1 - 25 of 7,424
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, PARP Inhibitor Trial in Pittsburgh

Not yet recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 8, 2022

Basal Cell Carcinoma Trial in Zürich (Cemiplimab Injection [Libtayo])

Recruiting
  • Basal Cell Carcinoma
  • Cemiplimab Injection [Libtayo]
  • Zürich, Switzerland
    University Hospital Zurich, Clinic of Dermatology
Nov 3, 2022

Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Tampa (PF-04449913)

Completed
Has Results
  • Myelodysplastic Syndrome (MDS)
  • Chronic Myelomonocytic Leukemia (CMML)
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 10, 2021

Pancreatic Ductal Adenocarcinoma Trial in Spain (Gemcitabine, Nab paclitaxel, NLM-001)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Santiago De Compostela, A Coruña, Spain
  • +5 more
Dec 5, 2022

Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)

Completed
Has Results
  • Adult Acute Myeloid Leukemia in Remission
  • Recurrent Adult Acute Myeloid Leukemia
  • Aurora, Colorado
  • +1 more
Dec 30, 2021

Basal Cell Carcinoma, Basal Cell Nevus Syndrome Trial in Australia (ASN-002)

Recruiting
  • Basal Cell Carcinoma
  • Basal Cell Nevus Syndrome
  • ASN-002
  • Brisbane, Queensland, Australia
  • +5 more
Feb 10, 2022

Basal Cell Nevus Syndrome, Gorlin Syndrome Trial in Oakland, New York (GDC-0449)

Completed
Has Results
  • Basal Cell Nevus Syndrome
  • Gorlin Syndrome
  • Oakland, California
  • +1 more
Dec 16, 2020

Acute Myeloid Leukemia Trial in Japan (PF-04449913, Low dose ARA-C (LDAC), Daunorubicin)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Nagoya, Aichi, Japan
  • +8 more
Jan 12, 2022

Carcinoma, Basal Cell Trial in Worldwide (cemiplimab)

Active, not recruiting
Has Results
  • Carcinoma, Basal Cell
  • Phoenix, Arizona
  • +70 more
Jun 30, 2022

Sclerodermoid Chronic GVHD (Disorder) Trial in Spain (Glasdegib)

Active, not recruiting
  • Sclerodermoid Chronic Graft-Versus-Host Disease (Disorder)
  • Barcelona, Spain
  • +5 more
Mar 16, 2022

Pancreatic Ductal Adenocarcinoma Trial in Baltimore (LDE225-600mg, Gemcitabine, nab-paclitaxel)

Terminated
Has Results
  • Pancreatic Ductal Adenocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 17, 2020

Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma, Metastatic Basal Cell Carcinoma Trial in Netherlands (Vismodegib,

Recruiting
  • Basal Cell Carcinoma
  • +10 more
  • Nijmegen, Gelderland, Netherlands
  • +7 more
Jul 14, 2022

Hepatocellular Carcinoma, Cirrhosis Trial in La Jolla (LDE225)

Completed
  • Hepatocellular Carcinoma
  • Cirrhosis
  • La Jolla, California
    UCSD Moores Cancer Center
Mar 3, 2019

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Metastatic Pancreatic Cancer Trial in Scottsdale, Baltimore, Philadelphia (Gemcitabine, nab-Paclitaxel, GDC-0449)

Completed
Has Results
  • Metastatic Pancreatic Cancer
  • Gemcitabine, nab-Paclitaxel, GDC-0449
  • Scottsdale, Arizona
  • +2 more
Apr 2, 2019

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting
  • Brain Tumor
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 20, 2022

Cancer Fusion Hybrids and Desmoplasia

Recruiting
  • Fusion Protein Expression
  • Bone Marrow Cells
    • Miaoli, Taiwan
      National Institute of Cancer Research, National Health Research
    May 30, 2022

    Metastatic Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma Trial in Bordeaux (Treatment with vismodegib)

    Completed
    • Metastatic Basal Cell Carcinoma
    • Locally Advanced Basal Cell Carcinoma
    • Treatment with vismodegib
    • Bordeaux, France
      Chu de Bordeaux
    Aug 17, 2022

    Extensive Stage Small Cell Lung Carcinoma, Recurrent Small Cell Lung Carcinoma Trial in United States (drug, biological, other)

    Completed
    Has Results
    • Extensive Stage Small Cell Lung Carcinoma
    • Recurrent Small Cell Lung Carcinoma
    • Scottsdale, Arizona
    • +300 more
    Dec 10, 2020

    Basal Cell Carcinoma Trial in Baltimore (Nivolumab, Ipilimumab, Relatlimab)

    Recruiting
    • Basal Cell Carcinoma
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Mar 10, 2022

    Recurrent Basal Cell Carcinoma Trial in United States (Patidegib Topical Gel, 2%, Patidegib Topical Gel, Vehicle)

    Terminated
    • Recurrent Basal Cell Carcinoma
    • Patidegib Topical Gel, 2%
    • Patidegib Topical Gel, Vehicle
    • Apple Valley, California
    • +13 more
    May 25, 2021

    Basal Cell Carcinoma, Basal Cell Carcinoma of Skin, Site Unspecified, Skin Cancer Trial in North Sydney (drug, procedure, other)

    Recruiting
    • Basal Cell Carcinoma
    • +3 more
    • North Sydney, New South Wales, Australia
      Melanoma Institute Australia
    Jun 9, 2022

    Acute Myeloid Leukemia Trial in Worldwide (PF-04449913, Low dose ARA-C (LDAC), Decitabine)

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • Birmingham, Alabama
    • +80 more
    Feb 19, 2020

    Locally Advanced Basal Cell Carcinoma Trial in Brescia (Sonidegib)

    Recruiting
    • Locally Advanced Basal Cell Carcinoma
    • Brescia, Italy
      Asst Degli Spedali Civili Di Brescia
    Aug 3, 2022

    Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma Trial in United States

    Not yet recruiting
    • Esophageal Adenocarcinoma
    • +2 more
    • Palo Alto, California
    • +5 more
    Jan 12, 2023